Pure Global
NCT04349254

Observational Study of Vision Improvement in Late Stage Dry AMD Patients

Observational Study of Vision Improvement in Late Stage Dry AMD Patients by a Low Vision Aid Device
Optimal Acuity Corporation·ClinicalTrials.gov·device·Device trialCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Dry Age-related Macular Degeneration
Drug/Device/Intervention
Corneal treatment by a low vision aid device
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Optimal Acuity Corporation
Location
Toronto, Canada
Timeline & enrollment
Phase
N/A
Start date
Aug 14, 2020
End date
Dec 31, 2020
Enrollment
17 participants
Primary outcome

CDVA

Summary

The purpose of this study is to assess the vision improvement achieved by patients with late
 stage dry age-related macular degeneration who received corneal treatments by a low vision
 aid device.

ICD-10 classifications
Peripheral retinal degenerationCorneal degenerationHereditary retinal dystrophyOptic atrophy in diseases classified elsewhereDisorders of choroid and retina
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04349254
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT04349254 through Pure Global AI's free database. This phase not specified trial is sponsored by Optimal Acuity Corporation and is currently Completed. The study focuses on Dry Age-related Macular Degeneration. Target enrollment is 17 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.